Carmignac Gestion 13D and 13G filings for Clearside Biomedical, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-13 12:19 pm Sale | 2022-12-31 | 13G | Clearside Biomedical, Inc. CLSD | Carmignac Gestion | 2,400,344 3.980% | -723,908 (-23.17%) | Filing |
| 2022-02-09 2:09 pm Sale | 2021-12-31 | 13G | Clearside Biomedical, Inc. CLSD | Carmignac Gestion | 3,124,252 5.200% | -416,709 (-11.77%) | Filing |
| 2021-02-12 12:25 pm Purchase | 2020-12-31 | 13G | Clearside Biomedical, Inc. CLSD | Carmignac Gestion | 3,540,961 7.300% | 3,540,961 (New Position) | Filing |